The China Radiation Dose Management Market was valued at $10.2 Million in 2023 and projected to reach to $22.5 Million by 2028, representing a compound annual growth rate of CAGR 17.1%. China's radiation dose management market is positioned for exceptional growth through 2028, driven by the nation's aggressive healthcare modernization agenda and increasing adoption of diagnostic imaging technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China's radiation dose management market is growing at 17.1% CAGR, nearly 3.3 percentage points faster than the global average of 13.8%, reflecting accelerated healthcare infrastructure investment and modernization initiatives across the country.
China's commitment to upgrading diagnostic imaging capabilities in hospitals and clinics is fueling demand for advanced radiation dose management solutions, particularly in tier-1 and tier-2 cities where healthcare spending is concentrated.
Strengthened radiation safety regulations and compliance requirements from Chinese health authorities are compelling healthcare facilities to adopt dose management systems, creating sustained market demand across public and private institutions.
The market is projected to more than double from $10.2 million in 2023 to $22.5 million by 2028, representing a $12.3 million increase in market value over the five-year forecast period.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | FLUOROSCOPY & INTERVENTIONAL IMAGING (Modality) |
| Forecast Period | 2023–2028 |
| Growth Rate | CAGR of 13.8% from 2023 to 2028 |
| Largest Segment | SOLUTIONS (Product & Service) |
| Market Size Base Year (Billions) | ~USD 0.34 (2023) |
| Revenue Forecast (Billions) | ~USD 0.65 (2028) |
| Segments Covered | Product & Service, Type, Modality, Mode Of Deployment, Revenue Model, Application, End User |
7 segment dimensions are covered across the global market.
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGERY CENTERS | 2.1 | 2.52 | 2.99 | 3.5 | 4.07 | 4.68 | 5.35 | 6.06 | 15.2 |
| DIAGNOSTIC AND IMAGING CENTERS | 0.99 | 1.2 | 1.44 | 1.7 | 2 | 2.32 | 2.68 | 3.06 | 16.4 |
| HOSPITALS AND HEALTHCARE SYSTEMS | 6.58 | 8.01 | 9.62 | 11.44 | 13.48 | 15.74 | 18.23 | 20.96 | 16.9 |
| OTHER END USERS | 0.49 | 0.6 | 0.72 | 0.86 | 1.01 | 1.17 | 1.36 | 1.56 | 16.7 |
| TOTAL | 10.16 | 12.33 | 14.76 | 17.5 | 20.55 | 23.92 | 27.61 | 31.64 | 16.5 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BIOMERIEUX S.A. | France | Public Company | Clinical Microbiology (culture media, VITEK, VIRTUO, ETEST, API),Molecular Syndromic & PCR (BIOFIRE, SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays & CLIA (VIDAS, Hybiome and related markers), |
| CERNER CORPORATION | United States | Private Company | Cerner Millennium EHR and core clinical/financial platforms,HealtheIntent population health, analytics, and real-world evidence,CareAware and device connectivity solutions, |
| GENERAL ELECTRIC | United States | Public Company | Commercial Engines & Services,Defense & Propulsion Technologies,Additive and Specialized Components, |
| BAYER AG | Germany | Public Company | Crop Science,Pharmaceuticals,Consumer Health, |
| GE HEALTHCARE | United States | Public Company | Imaging (CT, MR, X-ray, Molecular, Women’s Health),Advanced Visualization Solutions & Ultrasound / Image-Guided Therapies,Patient Care Solutions (Monitoring, Cardiology, Anesthesia, Maternal Infant), |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy Systems and Devices,Monitoring and Enterprise Informatics, |
| SECTRA AB | Sweden | Public Company | Imaging IT Solutions,Secure Communications,Business Innovation (orthopedics, education, cancer diagnostics IT), |
| AGFA-GEVAERT GROUP | Belgium | Public Company | Enterprise and Diagnostic Imaging (incl. DR, X-ray film, hardcopy, software, SmartXR),Industrial Inkjet (printers, inks, fluids for sign, display, packaging, industrial applications),Specialty Materials (synthetic papers, films, NDT, aerial, PCB, electrolysis membranes), |
| GUERBET | France | Public Company | MRI contrast media (DOTAREM, Elucirem, Artirem and related),CT and Cath lab iodinated contrast (Optiray, Xenetix/ScanBag, Telebrix Gastro and related),Barium and legacy agents (Micropaque/Microtrast, Conray/Cysto-Conray and related), |
| FUJIFILM HOLDINGS CORPORATION | Japan | Public Company | Healthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Business Innovation (office equipment, document solutions, graphic communications),Electronics (display, semiconductors, storage media, industrial equipment, fine chemicals), |
| INFINITT HEALTHCARE CO., LTD. | South Korea | Public Company | Enterprise Imaging (VNA, Enterprise Viewer, Unified Worklist, image sharing),Radiology PACS, Reporting, and Advanced Visualization (INFINITT Results, Xelis Fusion, DoseM, Exam Quality Reporting),Specialty Imaging (Mammo PACS, Cardiology Suite, Digital Pathology, Radiation Oncology, Ophthalmology), |
| MEDSQUARE | United States | Public Company | Ticketing and premium seating,Sponsorship, advertising, and naming rights,Media and league distributions, |
bioMérieux S.A. is a French public company founded in 1963 that employs 14,894 people. The company operates in the diagnostics and life sciences sector.
Cerner Corporation is a United States-based private company founded in 1979 with 25,150 employees. The company provides healthcare information technology solutions.
General Electric is a United States public company founded in 1892 with 57,000 employees. The company operates across multiple industrial and technology sectors.
Bayer AG is a German public company founded in 1863 with 87,757 employees. The company operates in pharmaceuticals, crop science, and consumer health.
GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees. The company provides medical imaging, diagnostics, and healthcare IT solutions.
Koninklijke Philips N.V. is a Netherlands-based public company founded in 1891 with 64,317 employees. The company operates in healthcare, consumer lifestyle, and lighting sectors.
Sectra AB is a Swedish public company founded in 1957 with 1,365 employees. The company specializes in medical imaging IT solutions and cybersecurity.
Agfa-Gevaert Group is a Belgian public company founded in 1867 with 4,211 employees. The company operates in imaging technology and healthcare IT.
Guerbet is a France-based public company founded in 1901 with 2,700 employees. The company develops and manufactures contrast media and medical imaging solutions.
Fujifilm Holdings Corporation is a Japan-based public company founded in 1934 with 73,526 employees. The company operates in imaging, healthcare, and materials technology.
Infinitt Healthcare Co., Ltd. is a South Korea-based public company founded in 2002 with 246 employees. The company provides healthcare IT and medical imaging solutions.
MedSquare is a United States-based public company founded in 2015 with 761 employees. The company operates in healthcare technology and medical imaging.
China's radiation dose management market was valued at $10.2 million in 2023 and is expected to reach $22.5 million by 2028.
China's radiation dose management market is projected to grow at a compound annual growth rate (CAGR) of 17.1% from 2023 to 2028.
Key drivers include China's healthcare modernization, increased adoption of diagnostic imaging, regulatory emphasis on radiation safety, and government initiatives promoting healthcare digitalization.
China's 17.1% CAGR significantly outpaces the global radiation dose management market CAGR of 13.8%, positioning China as a high-growth regional market.
Hospitals and diagnostic imaging centers across China are the primary adopters of radiation dose management technologies, driven by regulatory compliance and patient safety requirements.
The study involved four major activities to estimate the current size of the radiation dose management market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of Radiation Dose Management Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the Radiation Dose Management market. Primary sources from the demand side included personnel from hospitals (small, medium-sized, and large hospitals), primary care clinics, and stakeholders in corporate & government bodies.
The following is a breakdown of the primary respondents:

Others include sales managers, marketing managers, and product managers.
Note 1: Tiers of companies are defined on the basis of their total revenues in 2022. Tier 1 = >USD 500 million, Tier 2 = USD 100 million to USD 500 million, and Tier 3 = <USD 500 million.
Note 2: The RoW includes Latin America and the Middle East & Africa.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the radiation dose management market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the radiation dose management industry.
Radiation Dose Management Software Solution refers to a specialized software application designed to monitor, analyze, and manage the amount of ionizing radiation exposure that patients receive during medical imaging procedures. These solutions play a crucial role in enhancing patient safety by ensuring that healthcare providers can optimize radiation doses while maintaining diagnostic image quality. By employing Radiation Dose Management Software Solutions, healthcare providers can enhance their ability to deliver high-quality care while minimizing the risks associated with unnecessary or excessive radiation exposure. These solutions contribute to the ongoing effort to strike a balance between the benefits of medical imaging and the importance of radiation safety.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Radiation Dose Management Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report